scholarly journals Morphology of human Fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis—in vitro organ culture study

2006 ◽  
Vol 22 (4) ◽  
pp. 968-979 ◽  
Author(s):  
Agata Baczynska ◽  
Peter Funch ◽  
Jens Fedder ◽  
Hans Jørgen Knudsen ◽  
Svend Birkelund ◽  
...  
2013 ◽  
Vol 31 (10) ◽  
pp. 1514-1519 ◽  
Author(s):  
Zhu Dai ◽  
Kanghua Li ◽  
Zhiwei Chen ◽  
Ying Liao ◽  
Lezhong Yang ◽  
...  

2020 ◽  
Vol 64 (8) ◽  
Author(s):  
Ken B. Waites ◽  
Donna M. Crabb ◽  
Li Xiao ◽  
Lynn B. Duffy ◽  
Sixto M. Leal

ABSTRACT We performed in vitro susceptibility testing for eravacycline in comparison to 4 other antimicrobials against 10 Mycoplasma genitalium, 40 Mycoplasma hominis, 44 Mycoplasma pneumoniae, 20 Ureaplasma parvum, and 20 Ureaplasma urealyticum isolates. All eravacycline MICs were ≤0.25 μg/ml, except that for one isolate of M. genitalium, for which the MIC was 2 μg/ml. Eravacycline was markedly more potent than tetracycline, azithromycin, moxifloxacin, and clindamycin against all isolates tested, which included 37 macrolide, tetracycline, and/or fluoroquinolone-resistant organisms.


2009 ◽  
Vol 53 (5) ◽  
pp. 2139-2141 ◽  
Author(s):  
Ken B. Waites ◽  
D. M. Crabb ◽  
Lynn B. Duffy

ABSTRACT MICs were determined for an investigational ketolide, CEM-101, and azithromycin, telithromycin, doxycycline, levofloxacin, clindamycin, and linezolid against 36 Mycoplasma pneumoniae, 5 Mycoplasma genitalium, 13 Mycoplasma hominis, 15 Mycoplasma fermentans, and 20 Ureaplasma isolates. All isolates, including two macrolide-resistant M. pneumoniae isolates, were inhibited by CEM-101 at ≤0.5 μg/ml, making CEM-101 the most potent compound tested.


2003 ◽  
Vol 73 (5) ◽  
pp. 470-475 ◽  
Author(s):  
R. Moseley ◽  
R. J. Waddington ◽  
A. J. Sloan ◽  
A. J. Smith ◽  
R. C. Hall ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document